Privacy Policy

By accessing and using the Site, you hereby agree to the terms and conditions of this Privacy Policy.

Prestium Pharma, Inc. (hereinafter "Prestium Pharma," "we," "our," or "us") offers online resources designed to provide medical and product-related information and services through its Internet website (the "Site").  With this goal in mind, we have developed a Privacy Policy to inform you of how we use Personal Information (as defined below) collected from the Site.  We understand and respect that your privacy is important to you.  This policy does not apply to Personal Information collected from offline resources and communications, except in cases where such Personal Information is consolidated with Personal Information collected by Prestium Pharma online. This policy also does not apply to third-party online resources to which Prestium Pharma's Site may link, where Prestium Pharma does not control the content or the privacy practices of such resources.

Personal Information

Personal Information includes information that identifies or that is used by Prestium Pharma to identify an individual.  Some information that you may enter into forms or data fields on our Site is considered Personal Information.  Such information may include, but is not limited to, your name, address, e-mail address and telephone number.  Personal Information does not include personally non-identifiable information such as IP address, browser type, domain name and other anonymous statistical data.

Use of Personal Information

We use Personal Information to respond to your requests or to contact you via e-mail or by phone to inform you of products and services we may offer. If you request a service, we may need to contact you for additional information that may be required to fulfill your request. However, we will not provide your Personal Information to a third party without your permission, except when necessary to (a) comply with a legal obligation, (b) protect and defend our rights or property, (c) act in urgent circumstances to protect the personal safety of users of the Site or the public or (d) protect against legal liability.  Notwithstanding the foregoing, we may transfer your Personal Information to a purchaser of all or substantially all of Prestium Pharma's assets or in connection with Prestium Pharma's merger, consolidation, change of control or similar transaction.

We will take reasonable steps to protect Personal Information as it is transmitted from your computer to our online resources and servers, as well as to protect Personal Information in our possession from unauthorized access, disclosure, alteration or destruction.

We may use personally non-identifiable information and pool it with other information to track, for example, the total number of visitors to the Site.  We may also provide aggregate statistics about our customers, sales, Site traffic patterns and related Site information to reputable third parties, but these statistics will not include any Personal Information.

Accuracy of Information; Access

To keep Personal Information accurate, current and complete, please contact us as specified below.  We will exercise reasonable efforts either on our own initiative, or at your request, to update, correct or erase any incomplete, inaccurate or outdated Personal Information retained by us in connection with the operation of the Site.

Your Choices

You can always choose not to provide Personal Information on the Site.  However, doing so may prevent you from obtaining certain information or using certain areas of the Site.


We may change this Privacy Policy, modify or withdraw access to the Site, or the content of these pages at any time with or without prior notice.

Contact Information

To contact Prestium Pharma regarding this Privacy Policy or updates/changes to your Personal Information, please e-mail us at

Important Safety Information

Denavir should only be used on herpes labialis on the lips or face. Application to mucous membranes is not recommended. Denavir should not be used in patients with known hypersensitivity to the product or any of its ingredients.

There are no adequate and well-controlled Denavir studies in pregnant women; therefore, Denavir should be used during pregnancy only if clearly needed. There is no information on whether Denavir is excreted in human milk after topical administration; a decision whether to discontinue Denavir should take into account the importance of the drug to the mother. The effect of Denavir has not been established in immunocompromised patients. Denavir does not cure cold sores.

In clinical studies, the most common adverse reaction with Denavir was headache, which occurred in 5.3% of patients who received Denavir and 5.8% of patients who received placebo. Other adverse reactions with Denavir occurred in less than 2% of patients and included application site reaction, decreased sensitivity to touch/local anesthesia, taste perversion, and rash.

Other reported adverse reactions have included swelling of the mouth or throat, pain, alterations in sense of smell, abnormal touch sensation, itching, skin discoloration, and hives.

Denavir is available by prescription only. Please see the Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit, or call 1-800-FDA-1088.


DENAVIR is a nucleoside analog HSV DNA polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in adults and children 12 years of age and older.